Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × sargramostim × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 10 Melanoma 4 Ganglioneuroblastoma 4 Triple Negative Breast Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Adenoma, Islet Cell 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Transplant-Related Hematologic Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1

Interventions

ruxolitinib 8 fludarabine phosphate 3 bomedemstat 3 Whole-Body Irradiation 3 Tacrolimus 3 Specimen Handling 3 Mycophenolic Acid 3 Cyclophosphamide 3 Biopsy 3 fludarabine 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Melphalan 2 Injections 2 Busulfan 2 venetoclax 1 veliparib 1 piperine 1 pevonedistat 1 iadademstat 1 givinostat hydrochloride 1 givinostat 1 fedratinib 1 demethoxycurcumin 1 decitabine and cedazuridine drug combination 1 anagrelide 1 X-Rays 1 Valganciclovir 1 Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡